Targeting the Microtubules in Breast Cancer Beyond Taxanes: The Epothilones
Open accessThe DOI matches its Crossref record.
Abstract
Learning Objectives: After completing this course, the reader will be able to: Describe the mechanism of action of epothilones and the different epothilone analogs in clinical development.Discuss the current status and the results of phase II trials with epothilone analogs in metastatic breast cancer.Explain why epothilone may have utility in combination with other cytotoxic chemotherapeutic agents for treating metastatic breast cancer. CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Protein nanoparticles as drug carriers in clinical medicine
Hawkins, M. J., Soon-Shiong, P., & Desai, N. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.044 · Cited by 779
Zhang, B., Carroll, J., Trojanowski, J. Q., Yao, Y., Iba, M., Potuzak, J. S., Hogan, A.-M. L., Xie, S. X., Ballatore, C., Smith, A. B., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4922-11.2012 · Cited by 401
“Thus, the substantially lower EpoD doses used here could attenuate the adverse complications associated with MT-stabilizing drugs, such as immune cell depletion and the onset of peripheral neuropathy (Cortes and Baselga, 2007; Cheng et al., 2008; Bedard et al., 2010).”
BackgroundTubulin-Interactive Natural Products as Anticancer Agents
Kingston, D. G. I. (2009) · Journal of Natural Products · doi:10.1021/np800568j · Cited by 328
Is class III β-tubulin a predictive factor in patients receiving tubulin-binding agents?
Sève, P., & Dumontet, C. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70029-9 · Cited by 274
Füredi, A., Szebényi, K., Tóth, S., Cserepes, M., Hámori, L., Nagy, V., Karai, E., Vajdovich, P., Imre, T., Szabó, P., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.07.010 · Cited by 100
Metadata
- Authors
- Cortes, J., & Baselga, J.
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-03-01
- Volume
- 12
- Issue
- 3
- Pages
- 271-280
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- OpenAlex
- W2149783819
- Cited by
- 137
- References
- 0
- FWCI
- 9.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeting the Microtubules in Breast Cancer Beyond Taxanes: The Epothilones. https://app.cochat.ai/papers/10.1634/theoncologist.12-3-271
- The paper
- Cortes, J., & Baselga, J. (2007). Targeting the Microtubules in Breast Cancer Beyond Taxanes: The Epothilones. The Oncologist. https://doi.org/10.1634/theoncologist.12-3-271
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.